2023
DOI: 10.1002/hed.27354
|View full text |Cite
|
Sign up to set email alerts
|

Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes

Abstract: Background Distant metastasis (DM) development in Oropharyngeal Squamous Cell Carcinoma (OPSCC) represents an important prognostic factor. The identification of a phenotype of metastatic patients may better define therapeutic and follow‐up programs. Methods We included 408 patients with OPSCC, non‐metastatic at the time of diagnosis, and treated with curative intent. The Overall Survival (OS) analyses were performed and the impact of developing DM on survival was analyzed through Cox proportional‐hazard regres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…Exonuclease V is a DNA-specific exonuclease able to cleave linear single and double-stranded DNA strands into short oligos (<25 bp) ( 35 ). However, circular extrachromosomal episomes is resistant to this exonuclease ( 33 ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Exonuclease V is a DNA-specific exonuclease able to cleave linear single and double-stranded DNA strands into short oligos (<25 bp) ( 35 ). However, circular extrachromosomal episomes is resistant to this exonuclease ( 33 ).…”
Section: Resultsmentioning
confidence: 99%
“…Head and neck surgeons have also been actively involved in identifying better prognostication tools and safer treatment options to treat HPV-positive OPSCCs ( 19 , 20 ). Amidst these efforts, up to 15% of HPV-positive OPSCC patients continue to show resistance to current treatment modalities ( 22 , 35 ). For example, our clinical team at the McGill University Health Centre currently runs the NECTORS clinical trial.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The TNM system is the most widely utilised framework to stage LSCC and provide valuable predictions of survival 2 . The prognostic heterogeneity inherent to laryngeal neoplasms, particularly for those at advanced stages, has been the subject of extensive studies from our group and others aimed at identification of potential predictors [3][4][5][6][7][8][9][10] . Several prognostic factors have been implicated in LSCC, including disease stage, surgical margin status, tumour differentiation, extranodal extension (ENE), and the presence of lympho-vascular (LVI) or perineural invasion (PNI) [11][12][13] .…”
Section: Introductionmentioning
confidence: 99%